Who will benefit more from low-dose alteplase in acute ischemic stroke?
Xia WangKeon-Joo LeeTom James MoullaaliBeom Joon KimQiang LiHee-Joon BaeCheryl CarcelCandice DelcourtHisatomi ArimaShoichiro SatoThompson G RobinsonLili SongGuofang ChenJie YangJohn ChalmersCraig S AndersonRichard I LindleyMark Woodwardnull nullPublished in: International journal of stroke : official journal of the International Stroke Society (2019)
Use of low-dose alteplase may be preferable in acute ischemic stroke patients with a combination of favorable characteristics, including younger age, lower systolic blood pressure, mild neurological impairment, and no atrial fibrillation, diabetes mellitus, or premorbid symptoms.
Keyphrases
- low dose
- blood pressure
- atrial fibrillation
- acute ischemic stroke
- high dose
- heart failure
- hypertensive patients
- heart rate
- left ventricular
- left atrial
- oral anticoagulants
- catheter ablation
- direct oral anticoagulants
- blood glucose
- left atrial appendage
- glycemic control
- type diabetes
- percutaneous coronary intervention
- physical activity
- blood brain barrier
- venous thromboembolism
- coronary artery disease
- cerebral ischemia